# The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients

> **NCT02648932** · PHASE2 · TERMINATED · sponsor: **University of Chicago** · enrollment: 9 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)

## Interventions

- **BIOLOGICAL:** Haplo-Cord Transplant
- **PROCEDURE:** Matched Unrelated Donor Transplant

## Key facts

- **NCT ID:** NCT02648932
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02-04
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2021-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648932, "The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02648932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*